528 related articles for article (PubMed ID: 22009939)
1. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK
FASEB J; 2012 Feb; 26(2):628-38. PubMed ID: 22009939
[TBL] [Abstract][Full Text] [Related]
2. Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice.
Huang J; Viswakarma N; Yu S; Jia Y; Bai L; Vluggens A; Cherkaoui-Malki M; Khan M; Singh I; Yang G; Rao MS; Borensztajn J; Reddy JK
Am J Pathol; 2011 Aug; 179(2):703-13. PubMed ID: 21801867
[TBL] [Abstract][Full Text] [Related]
3. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
4. PPARα-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation.
Gao Q; Jia Y; Yang G; Zhang X; Boddu PC; Petersen B; Narsingam S; Zhu YJ; Thimmapaya B; Kanwar YS; Reddy JK
Am J Pathol; 2015 May; 185(5):1396-408. PubMed ID: 25773177
[TBL] [Abstract][Full Text] [Related]
5. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.
Zhang H; Shen WJ; Cortez Y; Kraemer FB; Azhar S
Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G72-86. PubMed ID: 23104557
[TBL] [Abstract][Full Text] [Related]
6. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.
Hashimoto T; Fujita T; Usuda N; Cook W; Qi C; Peters JM; Gonzalez FJ; Yeldandi AV; Rao MS; Reddy JK
J Biol Chem; 1999 Jul; 274(27):19228-36. PubMed ID: 10383430
[TBL] [Abstract][Full Text] [Related]
7. Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform [corrected].
Vluggens A; Andreoletti P; Viswakarma N; Jia Y; Matsumoto K; Kulik W; Khan M; Huang J; Guo D; Yu S; Sarkar J; Singh I; Rao MS; Wanders RJ; Reddy JK; Cherkaoui-Malki M
Lab Invest; 2010 May; 90(5):696-708. PubMed ID: 20195242
[TBL] [Abstract][Full Text] [Related]
8. Liver ACOX1 regulates levels of circulating lipids that promote metabolic health through adipose remodeling.
Lu D; He A; Tan M; Mrad M; El Daibani A; Hu D; Liu X; Kleiboeker B; Che T; Hsu FF; Bambouskova M; Semenkovich CF; Lodhi IJ
Nat Commun; 2024 May; 15(1):4214. PubMed ID: 38760332
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
Ide T; Tsunoda M; Mochizuki T; Murakami K
Med Sci Monit; 2004 Oct; 10(10):BR388-95. PubMed ID: 15448592
[TBL] [Abstract][Full Text] [Related]
10. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.
Gao M; Bu L; Ma Y; Liu D
PLoS One; 2013; 8(6):e65641. PubMed ID: 23762402
[TBL] [Abstract][Full Text] [Related]
11. Tbc1d1 deletion suppresses obesity in leptin-deficient mice.
Dokas J; Chadt A; Joost HG; Al-Hasani H
Int J Obes (Lond); 2016 Aug; 40(8):1242-9. PubMed ID: 27089993
[TBL] [Abstract][Full Text] [Related]
12. PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.
Xu Y; Denning KL; Lu Y
Biochem Biophys Res Commun; 2022 Jul; 613():47-52. PubMed ID: 35526488
[TBL] [Abstract][Full Text] [Related]
13. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis.
Misra P; Reddy JK
Biochimie; 2014 Mar; 98():63-74. PubMed ID: 24291192
[TBL] [Abstract][Full Text] [Related]
15. Absence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism.
Qi C; Zhu Y; Pan J; Usuda N; Maeda N; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
J Biol Chem; 1999 May; 274(22):15775-80. PubMed ID: 10336479
[TBL] [Abstract][Full Text] [Related]
16. Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.
Chan SM; Sun RQ; Zeng XY; Choong ZH; Wang H; Watt MJ; Ye JM
Diabetes; 2013 Jun; 62(6):2095-105. PubMed ID: 23349482
[TBL] [Abstract][Full Text] [Related]
17. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
[TBL] [Abstract][Full Text] [Related]
18. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
19. Lemon Balm Extract ALS-L1023 Regulates Obesity and Improves Insulin Sensitivity via Activation of Hepatic PPARα in High-Fat Diet-Fed Obese C57BL/6J Mice.
Lee D; Shin Y; Roh JS; Ahn J; Jeoong S; Shin SS; Yoon M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549364
[TBL] [Abstract][Full Text] [Related]
20. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
